You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 12, 2024

Fluorometholone - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for fluorometholone and what is the scope of freedom to operate?

Fluorometholone is the generic ingredient in eight branded drugs marketed by Pharmacia And Upjohn, Allergan, Novartis, Amneal, Abbvie, and Harrow Eye, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for fluorometholone. Three suppliers are listed for this compound.

Summary for fluorometholone
Drug Prices for fluorometholone

See drug prices for fluorometholone

Recent Clinical Trials for fluorometholone

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Maastricht University Medical CenterPhase 4
Navy Medical Center San DiegoPhase 4
Benha UniversityPhase 1

See all fluorometholone clinical trials

Pharmacology for fluorometholone
Medical Subject Heading (MeSH) Categories for fluorometholone

US Patents and Regulatory Information for fluorometholone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan FML-S fluorometholone; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 019525-001 Sep 29, 1989 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn OXYLONE fluorometholone CREAM;TOPICAL 011748-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal FLUOROMETHOLONE fluorometholone SUSPENSION/DROPS;OPHTHALMIC 216348-001 Jan 9, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novartis FLUOR-OP fluorometholone SUSPENSION/DROPS;OPHTHALMIC 070185-001 Feb 27, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.